Most Recent Articles by Jody A. Charnow, Editor
Radical cystectomy is associated with better long-term overall survival than trimodal therapy, new study shows.
Spike in PSA level after starting abiraterone does not affect progression-free or overall survival, study finds.
In a phase 2b trial, around half of patients taking the novel calcineurin inhibitor at a dose of 23.7 mg twice daily achieved complete remission at 48 weeks.
A patient experienced painful skin ulcers despite having normal renal function.
In a study, vonapanitase did not improve primary patency compared with placebo, but did improve secondary patency and fistula use for hemodialysis.
More Articles by Jody A. Charnow, Editor
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)